Colorectal Cancer Therapeutics Market, By Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, and Others), By Drug Class (Immunotherapy, Chemotherapy, and Targeted Therapy), By Sales Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Top Selling Drugs (5-Flurorouracil, Capecitabine, Irinotecan, Oxaliplatin, and Trifluridine & Tipiracil) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Market for treatments for colorectal cancer was valued at US$ 9.8 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 5.3% to reach US$ 16.36 billion by 2030.

One kind of malignant tumor on the big intestine's inner walls is colorectal cancer. This results from cells growing out of control, which can impact or spread to other areas of the body. Genetic inheritance and inflammatory bowel illness are common causes of this type of cancer. Constipation or diarrhea, weakness, exhaustion, altered bowel habits, dark or red blood in the stool, cramps, dyspnea, loss of weight, stomach pain, and bloating are all signs of colorectal cancer. These signs and symptoms could appear years after the tumor first appeared. The cancer is classified into different stages based on the type of attachment: stage 0, cancer found early on; stage 1, cancer found internally.